Summary
The current paper briefly reviews the definition
of the Chronic Fatigue Syndrome. Then, a number of recent
research studies which examine quality of life of CFS sufferers,
current methods of treatment, and long-term prognosis for
sufferers are reviewed in detail. It is concluded that Chronic
Fatigue Syndrome is frequently an extremely debilitating disorder
with no available effective treatments. Medical research has
recently demonstrated that a substantial proportion of individuals
with Chronic Fatigue Syndrome may remain severely impaired
indefinitely. Finally, qualification for disability benefits
is briefly reviewed with an emphasis on the situation in Canada.
Both the Federal Government and private insurance companies
in Canada must, and do, now consider CFS sufferers for disability
benefits under appropriate conditions.
The Chronic Fatigue Syndrome
While reports have been given in the medical
literature of disorders resembling what is now known as the
Chronic Fatigue Syndrome (CFS) for at least a century, serious
research attention was directed at this disorder only since
the 1980s. Responding to apparent epidemics in California/Nevada
and elsewhere, the Centers for Disease Control in the United
States published a case definition of CFS in 1988 (Holmes
et al, 1988) designed to allow the careful clinical and research
examination of the disorder.
In 1994, after the publication of
more than 600 scientific articles on CFS, a revised definition
was published, again under the aegis of the Centers for Disease
Control (Fukuda et al, 1994). The criteria for diagnosis are
presented in Table
I .
CF
Support contains a mixture of two patented fresh-cell extracts
specifically designed to combat Chronic Fatigue Syndrome;
NatCell Mesenchyme and NatCell
Adrenal,
combined in a scientific formula to support healthy adrenal
functions and maintain homeostasis.*
Atrium
Biotechnologies has developed a patented biotechnological
process
to isolate and concentrate molecules in their most natural
state.
NatCell CF Support
Quantity - 24 vials (1 box) - Frozen Product
NatCell
CF Support combats Chronic Fatigue Syndrome by providing
·
Nutritional support for a healthy adrenal function
·
Helps regulation of the hypothalamic-pituitary-adrenal axis
1
·
Has been shown to increase cellular metabolic activity by 166%
in vitro 2
·
Organ-specific glandular substances
·
Preservative free, 100% natural
·
24 servings per box
1
Ref.: AV Edward and CT Jones, J Anat 1993; 183:291-307 2
Ref.: Clinical studies on file at Atrium Biotechnologies Inc
Lloyd's Chronic Fatigue
Solution
Quantity: 24 vials - Frozen
Product
Specific Data (.pdf)
Lloyd's CF Solution contains a mixture of two patented
fresh-cell extracts
combined in an extra strength formula;
each vial contains 3.5 ml Adrenal, 3.5 ml Mesenchyme
This Product is Now
Called Lloyd's Power Solution
More About
Adrenal
Gland Extracts
This
product is now made from PORCINE!
NO MADCOW HERE! |
 |
| Chronic
Fatigue Syndrome Support Available On-line |
| |
|